In addition, it has been reported that enhanced ESPL1 expression might be the reason for the increased malignancy of non-small cell and small cell lung cancer, and that ESPL1 represents a potential target for molecular therapy of lung cancer (Zhang et al., 2016). The gene discussed is ESPL1; the disease is lung cancer.